Skip to main content
. 2010 Aug 16;7:191. doi: 10.1186/1743-422X-7-191

Figure 3.

Figure 3

(A) No significant changes in extracellular mass were detected in HCV patients related to genotype or duration of antiviral treatment. (B) Total body water is significantly reduced in HCV-infected patients with genotype 1. As demonstrated, TBW decreased with the duration of antiviral therapy for 48 weeks. (C) Phase angle was significantly decreased in patients with genotype 3. Interestingly, no alterations in PA were present in patients with genotype 1 treated for 48 weeks.